A research team led by Arun Sanyal, M.D., director of Virginia Commonwealth Universitys Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, and Philip Newsome, Ph.D., of Kings College London, has been involved in the clinical trials exploring the potential of semaglutide the GLP-1 receptor agonist used for Wegovy and Ozempic to treat people with this type of liver disease
Thats significant protection
This class of medications (similar medications to semaglutide) has been approved since 2005 for the treatment of diabetes
WeightWatchers builds several safety layers into its program
Typically, a 30-day prescription of Ozempic or Wegovy retails for around $1,000
Our experts are dedicated to creating customized weight loss plans that include the right semaglutide dosage for you, competitive pricing, and ongoing support